Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Active, not recruiting1
Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

active_not_recruiting133%
completed133%
enrolling_by_invitation133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruiting

Colorectal Cancer Screening in Cystic Fibrosis

NCT05362344
enrolling_by_invitationphase_4

Imaging Biomarkers of Pancreatic Function and Disease

NCT05659147
completednot_applicable

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

NCT06630637

Clinical Trials (3)

Showing 3 of 3 trials
NCT05362344

Colorectal Cancer Screening in Cystic Fibrosis

Active Not Recruiting
NCT05659147Phase 4

Imaging Biomarkers of Pancreatic Function and Disease

Enrolling By Invitation
NCT06630637Not Applicable

Monitoring Intermittent Fasting for Human Optimization Using Wearable Technology: An N-of-1 Study

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3